ArticleVeterinary oncology (London, England)2025
Preliminary evaluation of the safety and feasibility of toll-like receptor ligand CB101 combined with hypofractionated radiation therapy in canine head and neck cancer: a pilot study.
Audrey Ghanian et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.